Thus, NQO1:Catalase ratios in PDA tumor vs associated normal pancreas tissue potentially offer a significant therapeutic window that may be exploited using unique NQO1 bioactivatable drugs, such as ß-lap (ARQ761). Here, NQO1 is linked to Patent ductus arteriosus.